Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114476564> ?p ?o ?g. }
- W3114476564 endingPage "57" @default.
- W3114476564 startingPage "48" @default.
- W3114476564 abstract "Abstract Background & Aims Discontinuation of nucleos(t)ide analogues (NA) remains a debatable issue in HBeAg‐negative chronic hepatitis B (CHB). This study aimed to address the outcome of HBeAg‐negative CHB patients who discontinued NA therapy. Methods This prospective study included 57 non‐cirrhotic HBeAg‐negative Caucasian CHB patients who discontinued NA therapy after median virological remission of 6 years. All patients had regular blood tests. Virological relapse was defined as HBV DNA > 2000 IU/mL or >20 000 IU/mL and biochemical relapse as ALT > ULN (40 IU/mL) or >2xULN. All patients with retreatment predefined criteria restarted entecavir or tenofovir. Results Of the 57 patients, 29 remained without retreatment after median follow‐up of 65 months (range: 36‐87) following treatment discontinuation. At 3, 6, 12, 24, 36 and 48 months, cumulative rates of retreatment were 16%, 20%, 32%, 35%, 46% and 50%, while the proportion of patients with HBV DNA < 2000 IU/mL and ALT < ULN were 73%, 60%, 52%, 52%, 47% and 37% respectively. All patients had virological and biochemical response after retreatment. No patient developed liver failure, hepatocellular carcinoma or death. Cumulative rates of HBsAg loss were 2%, 4%, 7%, 10% and 20% at 3, 6, 12, 24 and 36 months. HBsAg levels < 100 IU/mL at the end of NA treatment could predict HBsAg loss ( P = .001). Conclusions Our study supports that NA therapy can be safely stopped in non‐cirrhotic patients with HBeAg‐negative CHB. Over a median follow‐up of more than 5 years, half of the patients remained without retreatment with a substantial proportion of them achieving functional cure." @default.
- W3114476564 created "2021-01-05" @default.
- W3114476564 creator A5000090464 @default.
- W3114476564 creator A5008950143 @default.
- W3114476564 creator A5013952423 @default.
- W3114476564 creator A5016318276 @default.
- W3114476564 creator A5021927949 @default.
- W3114476564 creator A5046139233 @default.
- W3114476564 creator A5051763409 @default.
- W3114476564 creator A5058412508 @default.
- W3114476564 creator A5074748626 @default.
- W3114476564 creator A5076221219 @default.
- W3114476564 creator A5091246846 @default.
- W3114476564 date "2020-12-29" @default.
- W3114476564 modified "2023-10-18" @default.
- W3114476564 title "Long‐term clinical outcome of HBeAg‐negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues" @default.
- W3114476564 cites W1969776963 @default.
- W3114476564 cites W1997115629 @default.
- W3114476564 cites W2000307707 @default.
- W3114476564 cites W2010814575 @default.
- W3114476564 cites W2013840689 @default.
- W3114476564 cites W2015676838 @default.
- W3114476564 cites W2017354290 @default.
- W3114476564 cites W2040760136 @default.
- W3114476564 cites W2046150771 @default.
- W3114476564 cites W2174723704 @default.
- W3114476564 cites W2178541136 @default.
- W3114476564 cites W2237172879 @default.
- W3114476564 cites W2508430734 @default.
- W3114476564 cites W2524578302 @default.
- W3114476564 cites W2603778119 @default.
- W3114476564 cites W2605785536 @default.
- W3114476564 cites W2626176186 @default.
- W3114476564 cites W2737414455 @default.
- W3114476564 cites W2751119670 @default.
- W3114476564 cites W2767742777 @default.
- W3114476564 cites W2791755372 @default.
- W3114476564 cites W2883810232 @default.
- W3114476564 cites W2904463945 @default.
- W3114476564 cites W2911997171 @default.
- W3114476564 cites W2915041848 @default.
- W3114476564 cites W2922025778 @default.
- W3114476564 cites W2947410103 @default.
- W3114476564 cites W2975550449 @default.
- W3114476564 doi "https://doi.org/10.1111/liv.14654" @default.
- W3114476564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33373114" @default.
- W3114476564 hasPublicationYear "2020" @default.
- W3114476564 type Work @default.
- W3114476564 sameAs 3114476564 @default.
- W3114476564 citedByCount "5" @default.
- W3114476564 countsByYear W31144765642021 @default.
- W3114476564 countsByYear W31144765642022 @default.
- W3114476564 countsByYear W31144765642023 @default.
- W3114476564 crossrefType "journal-article" @default.
- W3114476564 hasAuthorship W3114476564A5000090464 @default.
- W3114476564 hasAuthorship W3114476564A5008950143 @default.
- W3114476564 hasAuthorship W3114476564A5013952423 @default.
- W3114476564 hasAuthorship W3114476564A5016318276 @default.
- W3114476564 hasAuthorship W3114476564A5021927949 @default.
- W3114476564 hasAuthorship W3114476564A5046139233 @default.
- W3114476564 hasAuthorship W3114476564A5051763409 @default.
- W3114476564 hasAuthorship W3114476564A5058412508 @default.
- W3114476564 hasAuthorship W3114476564A5074748626 @default.
- W3114476564 hasAuthorship W3114476564A5076221219 @default.
- W3114476564 hasAuthorship W3114476564A5091246846 @default.
- W3114476564 hasConcept C126322002 @default.
- W3114476564 hasConcept C141071460 @default.
- W3114476564 hasConcept C203014093 @default.
- W3114476564 hasConcept C2522874641 @default.
- W3114476564 hasConcept C2775940106 @default.
- W3114476564 hasConcept C2776175608 @default.
- W3114476564 hasConcept C2777214474 @default.
- W3114476564 hasConcept C2777382497 @default.
- W3114476564 hasConcept C2777410769 @default.
- W3114476564 hasConcept C2777869810 @default.
- W3114476564 hasConcept C2778019345 @default.
- W3114476564 hasConcept C2778715236 @default.
- W3114476564 hasConcept C2780593183 @default.
- W3114476564 hasConcept C71924100 @default.
- W3114476564 hasConcept C90924648 @default.
- W3114476564 hasConceptScore W3114476564C126322002 @default.
- W3114476564 hasConceptScore W3114476564C141071460 @default.
- W3114476564 hasConceptScore W3114476564C203014093 @default.
- W3114476564 hasConceptScore W3114476564C2522874641 @default.
- W3114476564 hasConceptScore W3114476564C2775940106 @default.
- W3114476564 hasConceptScore W3114476564C2776175608 @default.
- W3114476564 hasConceptScore W3114476564C2777214474 @default.
- W3114476564 hasConceptScore W3114476564C2777382497 @default.
- W3114476564 hasConceptScore W3114476564C2777410769 @default.
- W3114476564 hasConceptScore W3114476564C2777869810 @default.
- W3114476564 hasConceptScore W3114476564C2778019345 @default.
- W3114476564 hasConceptScore W3114476564C2778715236 @default.
- W3114476564 hasConceptScore W3114476564C2780593183 @default.
- W3114476564 hasConceptScore W3114476564C71924100 @default.
- W3114476564 hasConceptScore W3114476564C90924648 @default.
- W3114476564 hasIssue "1" @default.
- W3114476564 hasLocation W31144765641 @default.
- W3114476564 hasOpenAccess W3114476564 @default.